MCC
GSK icon

Money Concepts Capital’s GSK GSK Stock Holding History

Money Concepts Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$780K Buy
14,877
+304
+2% +$16.1K 0.04% 347
2026
Q1 		$804K Buy
14,573
+184
+1% +$9.97K 0.04% 316
2025
Q4 		$706K Buy
14,389
+221
+2% +$10.3K 0.04% 300
2025
Q3 		$611K Sell
14,168
-954
-6% -$37.3K 0.04% 295
2025
Q2 		$581K Buy
15,122
+643
+4% +$24.6K 0.04% 290
2025
Q1 		$561K Buy
14,479
+425
+3% +$15.6K 0.04% 283
2024
Q4 		$475K Sell
14,054
-1,502
-10% -$54.1K 0.04% 298
2024
Q3 		$636K Buy
15,556
+348
+2% +$14.2K 0.05% 264
2024
Q2 		$586K Buy
15,208
+1,629
+12% +$68.5K 0.05% 268
2024
Q1 		$582K Sell
13,579
-148
-1% -$6.1K 0.05% 272
2023
Q4 		$509K Sell
13,727
-772
-5% -$27.7K 0.05% 273
2023
Q3 		$526K Buy
14,499
+685
+5% +$24.3K 0.06% 243
2023
Q2 		$492K Sell
13,814
-89
-0.6% -$3.19K 0.05% 255
2023
Q1 		$495K Sell
13,903
-4,340
-24% -$152K 0.03% 288
2022
Q4 		$641K Buy
18,243
+5,760
+46% +$192K 0.03% 375
2022
Q3 		$367K Sell
12,483
-1,098
-8% -$41.6K 0.02% 338
2022
Q2 		$743K Sell
13,581
-3,717
-21% -$205K 0.07% 229
2022
Q1 		$942K Buy
17,298
+3,911
+29% +$212K 0.05% 308
2021
Q4 		$738K Buy
+13,387
New +$696K 0.06% 245
2021
Q1 		$606K Sell
13,589
-331
-2% -$15K 0.05% 284
2020
Q4 		$640K Buy
+13,920
New +$639K 0.06% 254

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Money Concepts Capital's GSK Position: Q2 2026 in Review

Money Concepts Capital increased its GSK (GSK) stake by 2.1% in Q2 2026, buying an estimated $16.1K and bringing the position to 14,877 shares worth $780K. The position accounts for 0.04% of the portfolio, ranked #347.

Money Concepts Capital first reported a position in GSK in Q4 2020 and has held it in 21 quarters since. The position peaked at $942K in Q1 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Money Concepts Capital held 14,877 shares of GSK worth $780K as of Q2 2026.
  • Money Concepts Capital bought 304 GSK shares in Q2 2026, an estimated $16.1K.
  • GSK made up 0.04% of Money Concepts Capital's portfolio in Q2 2026, its #347 holding.
  • Money Concepts Capital first reported a position in GSK in Q4 2020 and has held it in 21 quarters since.
  • Money Concepts Capital's GSK position peaked at $942K in Q1 2022.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.